Next |
home / stock / repcf / repcf message board
Subject | By | Source | When |
---|---|---|---|
Check out $MYMX, an M&A potential target in | Trend-Setter | investorshub | 10/17/2018 3:53:58 PM |
Yup! Mymetics Corp. ($MYMX), a swiss based public | Trend-Setter | investorshub | 10/17/2018 3:51:02 PM |
There are 2...AMF$ and MGCL#. One Canadian, the | rushmann | investorshub | 10/14/2018 6:10:00 PM |
Which is the other company. Thanks! I'm letting | XBRIANX | investorshub | 10/14/2018 3:58:41 PM |
There are many sleepers among the 10k+ OTC | rushmann | investorshub | 10/13/2018 5:26:51 PM |
How is nobody aware of this stock ? | XBRIANX | investorshub | 10/13/2018 1:01:07 PM |
Well, looks like the deal with YOFOTO is | rushmann | investorshub | 10/11/2018 2:45:08 PM |
This is a big development!! This company is | rushmann | investorshub | 09/24/2018 7:50:02 PM |
Here's some links to get your DD started | Tailorgang44 | investorshub | 09/24/2018 4:09:21 PM |
Just starting to look at this, interesting the | tdeck | investorshub | 09/23/2018 2:29:38 AM |
Made a small error in my last post | Tailorgang44 | investorshub | 08/29/2018 4:24:54 PM |
wow I did not realize that about phase | copesjc | investorshub | 08/01/2018 9:35:29 PM |
Correct, RCH-01 is in phase II trials, testing | Tailorgang44 | investorshub | 08/01/2018 9:30:54 PM |
Yeah, that was my understanding with the trials | rushmann | investorshub | 07/31/2018 12:18:50 AM |
thanks....I was in about a year ago but | copesjc | investorshub | 07/30/2018 10:54:34 PM |
Like many biotech's small and large, it's take | rushmann | investorshub | 07/30/2018 10:49:24 PM |
agreed, totally under the radar | copesjc | investorshub | 07/30/2018 10:45:17 PM |
Repcf's OS is very low compared to the | rushmann | investorshub | 07/30/2018 3:53:25 PM |
Phase 1 clinical studies on all three products | rushmann | investorshub | 07/30/2018 3:49:31 PM |
Repcf is completely overlooked by the market, but | rushmann | investorshub | 07/30/2018 3:46:48 PM |
News, Short Squeeze, Breakout and More Instantly...
RepliCel Life Sciences Company Name:
REPCF Stock Symbol:
OTCMKTS Market:
RepliCel Life Sciences Website:
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developi...
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise ™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliC...
After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy products VANCOUVER, BC / ACCESSWIRE / July 28, 2022 / RepliCel Life Sciences ...